Articles tagged with Medical Genetics
A team of computer engineers developed PhyloFrame, a machine-learning tool that accounts for ancestral diversity in genetic data. This improves precision medicine outcomes by predicting differences between subtypes of diseases and suggesting personalized treatments regardless of patient ancestry.
Researchers outline critical safeguards needed to balance public health benefits with Indigenous data sovereignty rights. The study highlights the risks of DNA persistence in wastewater samples, which can reveal sensitive information about community health.
Researchers discovered a genetic mutation that increases glycine decarboxylase enzyme, linked to schizophrenia behaviors in mice. The study provides a direct genetic link to psychosis and sheds light on the biochemical pathways involved.
A groundbreaking study analyzed data from over 78,000 cancer patients to identify nearly 800 genetic changes impacting survival outcomes. The research also discovered genes significantly associated with survival in various cancers, such as breast, ovarian, skin, and gastrointestinal cancers.
A large-scale study has identified genetic overlaps in 72 long-term health conditions associated with ageing, revealing opportunities for new prevention and treatment strategies. The research also found that specific genes are linked to co-occurring conditions, leading to a more personalized approach to care.
Researchers developed a method to detect H3K27M-mutant droplets from circulating tumor DNA in cerebrospinal fluid, enabling early diagnosis and treatment of leptomeningeal disease. This approach improved survival rates for patients with diffuse midline gliomas.
The International Alliance for Primary Immunodeficiency Societies has partnered with Rockefeller University Press to launch the Journal of Human Immunity, an open-access journal focused on human immunity and inborn errors of immunity. The journal aims to provide a platform for groundbreaking research and attract top-tier submissions.
Researchers identified a novel genetic risk factor for SARS-CoV-2 infection, linking a PTPN2 variant to increased ACE2 expression and susceptibility. The study suggests Tofacitinib may mitigate this risk, offering new treatment options for patients at higher genetic risk.
Researchers found that bumetanide treatment normalizes neonatal social communication in newborn pups with the fragile X mutation, but reduces post-pubertal social interaction. The study suggests stage-specific effects on social development and raises questions about timing and dosing of bumetanide for targeted interventions.
Scientists investigated the role of ancient VR type-1 (ancV1R) receptor in pheromone detection using knockout mice. The study found that ancV1R-deficient female mice had impaired pheromone detection and exhibited abnormal sexual behavior.
A new University of Texas at Arlington study provides a comprehensive genetic map of the common bedbug Cimex lectularius, enhancing scientific investigations into pesticide resistance and developing targeted pest control strategies.
The American Heart Association warns hunters about the increased risk of heart attack and stroke due to exertion, cold temperatures, and excitement. Hunters should recognize symptoms, take breaks, and have a plan in case of emergencies. Learning Hands-Only-CPR can also save lives.
A team of researchers has identified a genetic link between rare brain malformations and protein folding defects in children. The study found that specific genetic changes can affect the function of proteins within cells, leading to abnormal cell behavior.
Researchers found that female mouse models of Rett syndrome have a mosaic-like distribution of cells expressing wild-type and mutant MeCP2 protein, leading to dysregulated genes. The study also discovered an unusual disease progression, with females having more dysregulated genes at the pre-symptomatic stage than later on.
Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.
A genome-wide association study found that three sequence variants in genes CCDC141 and SCN10A increase the risk of rhythm disturbances in individuals with accessory pathways. These variants are common, affecting up to 62% of carriers, and associate with increased conduction velocity and heart rate regulation.
Researchers at CNIC discover clonal hematopoiesis as a new cause of atherosclerosis, while identifying the ancient medication colchicine as a potential treatment. Clonal hematopoiesis is linked to an increased risk of cardiovascular disease, with no influence on the progression of mutated blood cells.
A study published at Uppsala University found that chronic cough is hereditary, with a 50% increased risk for offspring if one parent has the condition. The research also revealed differences in care between regions and highlights the need for better guidelines.
Researchers found large language models are more accurate with concise, textbook-like medical questions than patient-written summaries. The models achieved higher accuracy when using standardized language, but struggled with variable phrasing and format of patient write-ups.
The study reveals that the TAL1-microRNA axis is involved in the development and progression of T-cell acute lymphoblastic leukemia. The inappropriate expression of TAL1 leads to the downregulation of tumor suppressor miR-146b-5p, enhancing invasive properties of leukemia cells.
The Collaborative Ethics model, developed by Jeantine Lunshof and Julia Rijssenbeek, aims to address ethical implications of emerging technologies from fundamental discoveries. By integrating philosophical and ethical reassessment into research processes, the model facilitates decision points for researchers and ethicists.
A new genetic cause of obesity has been discovered, linking it to the SMIM1 gene variant. People with this variant tend to expend less energy when at rest, leading to excess weight and increased risk of obesity.
A study using induced pluripotent stem cells has revealed that inflammation triggered by retrotransposons and interferon signaling causes atherosclerosis in Werner syndrome patients. The researchers propose targeting the interferon signaling pathway as a potential treatment for reducing stroke and heart attacks.
Researchers have found that approximately one in 40 human bone marrow cells carry massive chromosomal alterations without causing any apparent disease or abnormality. Cell samples from people over 60 tend to have higher numbers of cells with such genomic alterations, suggesting a possible connection to ageing-related diseases.
The study highlights the importance of protease-activated receptors (PARs) in cancer growth and development, with PH-binding motifs identified as a key platform for drug design. The researchers suggest that targeting PARs could provide an alternative to current oncogenic pathways.
Mutations in the MAGEL2 gene lead to truncated, non-functional proteins accumulating in the cell nucleus, causing congenital malformations and intellectual disability. Researchers aim to develop patient-specific gene therapies to prevent altered protein synthesis and address this rare disease without treatment.
A large-scale study has identified over 2,000 genetic signals associated with blood pressure, providing a more detailed understanding of the complex trait. The findings lead to improved polygenic risk scores, which can predict blood pressure and hypertension risk.
The study provides a comprehensive understanding of TRAF7 syndrome, a rare neurological disorder characterized by cardiac, facial, and digital abnormalities. The research highlights the importance of comprehensive clinical assessment and proposes evidence-based guidelines for managing patients with TRAF7-related CAFDADD syndrome.
Scientists have identified the genetic mutation that causes SCA4, a progressive neurological disorder. The mutated gene ZFHX3 leads to impaired protein recycling in nerve cells, causing symptoms such as difficulty walking and balancing. This discovery opens the door to potential treatments for both SCA4 and another related form of ataxia.
A machine learning system called AI-MARRVEL, developed by Baylor College of Medicine, has shown promising results in diagnosing rare Mendelian disorders. The system consistently ranked diagnosed genes as the No. 1 candidate in twice as many cases than other benchmark methods.
Individuals at high genetic risk of obesity needed higher daily step counts to reduce obesity risk. Population-based recommendations may underestimate physical activity needed among those at high genetic risk.
Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.
Researchers discovered two novel GNE gene mutations that may cause a rare blood disorder called macrothrombocytopenia. The mutations affect the synthesis of sialic acid, critical for brain development and angiogenesis. Further studies are needed to understand the mechanism underlying this disorder and explore therapeutic interventions.
Researchers analyzed Beethoven's DNA to investigate his genetic musical predisposition, finding an unremarkable polygenic score compared to population samples. The study suggests that while DNA contributes to musical skills, environment plays a key role in musical ability and engagement.
Researchers propose combining osimertinib with gefitinib to increase progression-free survival rates in EGFR-mutant lung cancer patients. A comprehensive PC approach could dramatically boost PFS for 80% of patients, eliminating harm and improving treatment outcomes.
Researchers created a first-of-its-kind super minigene to study the Survival Motor Neuron 2 (SMN2) gene, which causes spinal muscular atrophy. The compact model allows scientists to see how changes play out across the entire gene expression process.
Researchers optimized polygenic risk scores using ancestrally diverse genomic data to improve accuracy across diverse populations. The recalibrated tests provided a more accurate assessment of disease risk for individuals with varied ancestral backgrounds.
Recent literature review highlights epicardial adipose tissue, chronic inflammation, and autonomic nervous system imbalance as key AF pathogenic factors. Clinical management trends include wearable devices for continuous monitoring and the 4S-AF scheme for comprehensive assessment.
Researchers from Osaka University have identified erythromycin as a potential treatment for myotonic dystrophy type 1, a genetic disease characterized by progressive muscular weakness. The antibiotic showed acceptable safety and tolerability profiles in a phase 2 clinical trial, with some patients experiencing significant improvements ...
A team of international researchers has reported the first high-resolution images and structural details of the human genetic element LINE-1, which is implicated in various diseases. The study provides a target for potential new treatments, particularly for cancer, autoimmune disorders, neurodegeneration, and even aging.
A single-nucleotide polymorphism in non-coding RNA AMANZI drives the activation and deactivation of interleukin-1β, affecting the immune response to tuberculosis vaccination. The discovery opens up new possibilities for guiding the immune system.
A research team identified two different RAD50 variants in a patient with progressive bone marrow failure and immunodeficiency, leading to loss of function of the MRN complex. The findings suggest that RAD50 deficiency/Nijmegen breakage syndrome-like disorder is characterized by growth retardation and microcephaly.
Researchers have identified a gene called LHPP that interacts with stress to mediate aspects of treatment-resistant MDD in an animal model. Increased expression of LHPP aggravated depression-like behaviors by dephosphorylating two protein kinases, CaMKIIα and ERK.
A study of 2,361 mother-child pairs found that prenatal lead exposure is associated with an increased risk of cognitive developmental delay (CDD) in children, particularly those with a high genetic risk. This suggests that integrating genetic factors into assessments of CDD risk may improve children's cognitive ability.
A team of researchers discovered two genetic genes that predispose people to Raynaud's phenomenon: ADRA2A and IRX1. These variations cause small blood vessels to contract in response to stress or cold, leading to vasospasms and limited blood flow. The study could lead to effective treatments for the condition.
Researchers discovered that a mutation in the gene ACTA2 causes moyamoya disease and strokes in young children. The mutation leads to dysfunctional smooth muscle cells in arteries, resulting in blockages and increased risk of stroke. Understanding this mechanism could lead to new treatments for moyamoya disease.
Research identifies genetic overlap between schizophrenia and cardiovascular disease (CVD) risk factors, particularly smoking initiation and BMI. The study found that people with schizophrenia have a genetic propensity to smoking and a reduced genetic risk of obesity.
Researchers identified distinct genomic characteristics that impact prognosis for patients with triple negative apocrine carcinoma. The study confirmed a five-year disease-free survival rate of 92.2% for these patients, significantly higher than those diagnosed with other types of TNBC.
Researchers discovered that a small subpopulation of AIB1-expressing cells in breast cancer enables invasion and metastasis. The study suggests that these subpopulations play a crucial role in tumor growth and spreading to distant sites.
A team of Chinese and UK researchers has identified superoxide dismutase 1 (SOD1) as a potential target for reversing drug resistance in ovarian cancer. By using nanoparticles to deliver siRNA that reduces SOD1 levels, the study showed reduced growth and decreased resistance to cisplatin in female mice.
A genetic study of 44,396 British people of Bangladeshi and Pakistani ancestry found that 57% have a genetic variant that renders clopidogrel ineffective in preventing recurrent heart attacks. People with two loss of function variants were more than three times more likely to experience recurrent heart attacks due to treatment failure.
Researchers are studying the characteristics of fragile X-associated tremor ataxia syndrome (FXTAS), aiming to develop treatments for this debilitating condition. The study focuses on understanding the phenotype of FXTAS, including its progression and impact on males and females.
Researchers identified novel genetic associations between AD and modifiable risk factors, including high HDL cholesterol concentrations and systolic blood pressure. These findings may inspire new drug targets and improved prevention strategies for AD.
Researchers have created the first humanized mouse model for Congenital Adrenal Hyperplasia, a rare genetic disease affecting 1 in 15,000 births. The mouse model accurately mimics human symptoms and allows for testing of novel treatments and stem cell therapies.
Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.
A new study reveals the mechanism of BRCA2's DNA repair function, understanding its role in breast and ovarian cancer development. The findings also provide insights into developing targeted cancer therapies by inhibiting DNA repair mechanisms.
Experts advocate for genetic testing to identify MS patients at high risk of developing progressive multifocal leukoencephalopathy (PML), a devastating side effect from medications. The availability of such testing could allow physicians to use alternative therapies, reducing the risk of PML.
Researchers have successfully used AAV1.NT-3 gene therapy to improve muscle physiology and prevent age-related sarcopenia in mice. The treatment resulted in restored muscle mass, strength, and neural connections, offering a potential new option for managing this debilitating condition.
Researchers at Martin-Luther-Universität Halle-Wittenberg have found a new treatment for ADCY5-related dyskinesia using the asthma drug theophylline. The treatment has been shown to reduce symptoms and improve quality of life in affected individuals.
The HALP score, a novel immune-nutritional marker, has been linked to prognostic ability in different cancer types. It integrates indicators of immune status and nutritional status, showing promise as a cost-effective biomarker.